Research Article

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

Figure 1

Histological features in Groups 1, 2, 3 depicting lesions of ulcers with surrounded granulation tissue, normal mucosa or healing sites (colitis in remission). (a) extensive chronic ulcer (H/E ×25). (b) Ulcer (arrow) and regenerating adjacent epithelium (arrows) (H/E ×100). (c) Base of ulcer covered by granulation tissue (arrows) (H/E ×200). (d) Normal mucosa (arrow) and acute ulcer (arrows). (e) Healing site of previous ulcer (H/E ×200). Reepitheliastion (arrow) loss of crypts and fibrosis (arrows). (f) Healed site and regenerating crypts (arrow heads) reepithelialization (arrows) (H/E ×100).
(a)
(b)
(c)
(d)
(e)
(f)